KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Arcosa (ACA) EPS (Weighted Average and Diluted) (2017 - 2026)

Arcosa's EPS (Weighted Average and Diluted) history spans 10 years, with the latest figure at $0.77 for Q1 2026.

  • On a quarterly basis, EPS (Weighted Average and Diluted) rose 60.42% to $0.77 in Q1 2026 year-over-year; TTM through Mar 2026 was $4.53, a 184.91% increase, with the full-year FY2025 number at $4.24, up 121.99% from a year prior.
  • EPS (Weighted Average and Diluted) hit $0.77 in Q1 2026 for Arcosa, down from $1.06 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for ACA hit a ceiling of $3.18 in Q4 2022 and a floor of -$0.16 in Q4 2024.
  • Historically, EPS (Weighted Average and Diluted) has averaged $0.9 across 5 years, with a median of $0.79 in 2022.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): surged 1573.68% in 2022 and later plummeted 128.57% in 2024.
  • Tracing ACA's EPS (Weighted Average and Diluted) over 5 years: stood at $3.18 in 2022, then plummeted by 82.39% to $0.56 in 2023, then crashed by 128.57% to -$0.16 in 2024, then surged by 762.5% to $1.06 in 2025, then decreased by 27.36% to $0.77 in 2026.
  • Business Quant data shows EPS (Weighted Average and Diluted) for ACA at $0.77 in Q1 2026, $1.06 in Q4 2025, and $1.48 in Q3 2025.